CDx Diagnostics®

CDx Diagnostics®

Medical and Diagnostic Laboratories

Suffern, NY 4,014 followers

Empowering Physicians to Preempt Cancer ℠

See jobs Follow

About us

The mission of CDx Diagnostics® is to provide clinicians with easily implemented, cost-effective tools to preempt cancer through enhanced detection of precancerous cellular changes. This is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods. CDx tests require only a few minutes of practice time, are highly cost-effective, widely reimbursed, and address a recognized critical gap in the current diagnostic standard of care that results in thousands of otherwise unnecessary cancer deaths each year. Routine clinical use of CDx testing has already detected thousands of precancerous cells that would otherwise have been missed in time for effective endoscopic treatment and application of the CDx diagnostic platform to prevent cancers of the bile duct, stomach, and IBD affected colon is currently in progress. About WATS3D WATS3D addresses the major inadequacies inherent in current random forceps biopsy testing of the esophagus. In just a few minutes, endoscopists can easily obtain a wide area, full-thickness transepithelial specimen for computer-assisted 3D laboratory analysis prior to diagnosis by any WATS3D certified pathologist. In large multicenter clinical trials, WATS3D has been found to significantly increase the detection rate of both Barrett’s esophagus and esophageal dysplasia. The high sensitivity and inter-observer agreement of WATS3D is due to the larger tissue area sampled, and the proprietary 3-Dimensional computer imaging system that is based on an artificial intelligence algorithm developed as part of the U.S. Strategic Defense Initiative missile defense program. To learn more about WATS3D, visit www.wats3d.com.

Website
http://www.cdxdiagnostics.com
Industry
Medical and Diagnostic Laboratories
Company size
51-200 employees
Headquarters
Suffern, NY
Type
Privately Held
Founded
2010
Specialties
Detection of Esophoageal Dysplasia & Cancer, Early Detection of Barrett's Esophagus, Detection of Laryngeal Dysplasia & Cancer, Prevention of Oral Cancer, Prevention of Esophageal Cancer, Screening for Barrett's Esophagus, Surveillance of Barrett's Esophagus, EGD, esophagogastroduodenoscopy, Prevention of Oral Dysplasia, GERD, Heartburn, Endoscopy, Gastroenterology, GI, and Surgery

Locations

Employees at CDx Diagnostics®

See all employees

Updates

Similar pages

Browse jobs

Funding

CDx Diagnostics® 1 total round

Last Round

Series unknown

US$ 11.0M

See more info on crunchbase